December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

41.98 +0.67 (+1.62%)
Streaming Delayed Price Updated: 1:57 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 300 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Insiders Buying Heska, B. Riley Financial And 2 Other Stocks ↗
Although US stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
From Scholar Rock
Via Business Wire
News headline image
Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside ↗
 
Via Benzinga
News headline image
Where Scholar Rock Holding Stands With Analysts ↗
  Analysts have provided the following ratings for Scholar Rock Holding (NASDAQ:SRRK) within the last quarter: 
Via Benzinga
News headline image
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Scholar Rock
Via Business Wire
News headline image
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... 
Via Benzinga
News headline image
Salesforce To $225? Plus Mizuho Predicts $135 For VMware ↗
Mizuho cut the price target on Salesforce, Inc. (NYSE: CRM) from $235 to $225. Mizuho analyst Gregg Moskowitz maintained the stock with a Buy rating. Salesforce shares rose 0.9% to $160.06 in... 
Via Benzinga
News headline image
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
News headline image
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Participate in Upcoming Investor Conferences
From Scholar Rock
Via Business Wire
News headline image
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Over $1 Million Bet On Scholar Rock Holding? 3 Stocks Insiders Are Buying ↗
Although US stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
News headline image
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
From Scholar Rock
Via Business Wire
News headline image
Expert Ratings for Scholar Rock Holding ↗
Over the past 3 months, 4 analysts have published their opinion on Scholar Rock Holding (NASDAQ:SRRK) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
News headline image
Scholar Rock to Present at Upcoming ACCP Annual Meeting and World CB & CDx Summit
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
From Scholar Rock
Via Business Wire
News headline image
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.